Urinary retention is a serious medical condition that affects millions of people worldwide and can lead to significant ...

Proper urinary elimination is a key indicator of your overall health, especially as you get older. If your ability to urinate is impaired, it can cause a wide variety of other conditions. Impaired ...

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ...

Myrbetriq (mirabegron) is a brand-name drug that’s prescribed for overactive bladder in adults and certain children. It’s an extended-release medication. As with other drugs, Myrbetriq can cause side ...

The approval was based on data from the pivotal phase 3 EMPOWUR study. The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron; Urovant Sciences) for the treatment of overactive ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses. Patients with recurrent low-grade intermediate-risk ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. The day after I had kidney stone ...